In a landmark study to be published by The Lancet, it has been revealed that global immunization efforts have been instrumental in saving an estimated 154 million lives over the...

Cancer, often referred to as the monster of our society, claims the lives of hundreds of thousands of individuals each year. In the United States alone, more than 600,000 people...

In 2019, Gary Keblish’s life took a sudden turn when what he thought was just a harmless mole revealed itself as a lurking menace: melanoma, advanced and menacing. “I felt...

In a significant stride towards revolutionizing cancer treatment, Cartherics Pty Ltd (“Cartherics”), a pioneering biotechnology firm specializing in immune cell therapies, has announced a collaborative research agreement with TiCARos Co...

In a monumental stride towards combatting one of Africa’s most insidious diseases, healthcare workers in West Africa have embarked on a historic endeavour, administering groundbreaking malaria vaccines. Developed after decades...

In a significant development for lung cancer treatment, the European Commission has granted approval for KEYTRUDA, an innovative therapy developed by Merck, for the treatment of resectable non-small cell lung...

4D Molecular Therapeutics (4DMT), a leading biotechnology company, is gearing up for a breakthrough phase 3 trial of its inhaled gene therapy, 4D-710, as a drug may result in patients...

Cancer continues to be one of the most formidable challenges to global health, claiming millions of lives each year. However, amidst this grim reality, the realm of cancer therapy is...

In March 20, 2024, a significant milestone in global health collaboration unfolded as the International Vaccine Institute (IVI) and Biological E. Limited (BE) embarked on a groundbreaking partnership. This initiative...

In a landmark decision hailed as a significant stride forward in pediatric immunization, Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for their groundbreaking 20-valent...

In a captivating development poised to advance the fight against cancer, BioNTech SE, a pioneer in mRNA-based therapies, unveiled a showcase of clinical trial data for select candidates from its...

The £14.25m Engineered Genetic Control Systems for Advanced Therapeutics Hub will establish improved gene therapy techniques for patients with serious conditions. It will create new biological tools to improve the...

The FDA approved trofinetide about a year ago as the first drug for treating Rett syndrome, a rare genetic disorder caused by mutations in the MECP2 gene. Researchers in Shanghai,...

Orchard Therapeutics, recently acquired by Kyowa Kirin, has set the wholesale acquisition cost (WAC) for their gene therapy at $4.25 million, the highest of any drug in the country. This...

NeuExcell Therapeutics has achieved a significant milestone by successfully dosing the first patient with their groundbreaking NeuroD1 gene therapy product, NXL-004, aimed at treating malignant glioma, a highly aggressive form...

Mabwell (688062.SH), an innovative biopharmaceutical company with a complete industry chain, has received approval from the U.S. Food and Drug Administration (FDA) for its clinical trial application of the B7-H3...

WuXi Advanced Therapies has secured FDA approval for the manufacturing of Iovance’s AMTAGVI™ (lifileucel), marking a significant milestone as the first and only one-time, individualised T-cell therapy to gain U.S....

In a collaborative effort, global biologics Contract Development and Manufacturing Organisation (CDMO), BioCina Pty Ltd., and NovaCina Pty Ltd., a global fill-and-finish CDMO, have unveiled a strategic partnership. This collaboration...

In a significant move poised to reshape Singapore’s biopharmaceutical landscape, China’s WuXi Biologics has embarked on a groundbreaking journey with the establishment of its new Contract Research, Development, and Manufacturing...

In a groundbreaking achievement, scientists have announced a significant advancement in the fight against HIV, the virus that causes AIDS. Employing the revolutionary CRISPR gene-editing technology, researchers claim to have...

The University of Oxford has taken a significant step in the fight against the deadly Nipah virus by initiating human testing of an experimental vaccine. This virus, which causes brain...